Is LIVN or NDRA more undervalued in 2026?

CirclFi compares LivaNova PLC (LIVN) and ENDRA Life Sciences Inc. (NDRA) using 13 institutional-grade valuation models. LIVN has a Quality of Company score of 8.7/10 while NDRA scores 3.6/10.

Which is a better buy — LIVN or NDRA?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do LIVN and NDRA valuations compare?

LIVN at $73.80 and NDRA at $5.50 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

LIVN vs NDRA Valuation Comparison 2026 — Intrinsic Value Analysis

LIVN

Electromedical & Electrotherapeutic Apparatus

LivaNova PLC

Quality

8.7

out of 10

Value Trap

SAFE

Price

$73.80

Last close

Models

13/13

Active

NDRA

Electromedical & Electrotherapeutic Apparatus

ENDRA Life Sciences Inc.

Quality

3.6

out of 10

Value Trap

LOW

Price

$5.50

Last close

Models

6/13

Active

Model-by-Model Comparison

Model	Type	LIVN Fair Value	LIVN Upside	NDRA Fair Value	NDRA Upside
Bayesian DCF	Intrinsic	$27.36	-62.9%	$1.47	-73.4%
Earnings Power Value	Intrinsic	$26.31	-64.4%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$1.25	-98.3%	$9.64	+75.3%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for LIVN vs NDRA — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

LIVN vs NDRA — Which Stock Is More Undervalued?

LIVN scores higher with a 8.7/10 quality rating vs NDRA's 3.6/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing LivaNova PLC (LIVN) and ENDRA Life Sciences Inc. (NDRA) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

LIVN currently trades at $73.80 with a QOC of 8.7/10, while NDRA trades at $5.50 with a QOC of 3.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).